Meanwhile, the AKT/mTOR pathway plays a significant role in the initiation and progression events of colorectal cancer, including migration, invasion, and drug resistance, and it is recognized as a striking therapeutic target [60]. The gene discussed is AKT1; the disease is colorectal cancer.